Marshall Wace’s HOOKIPA Pharma HOOK Stock Holding History

Marshall Wace’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,427	Closed	-$21.4K	–	2413
2023 Q2	$21.4K	Buy	+2,427	New	+$26.9K	﹤0.01%	2389

Other funds holding HOOK

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace's HOOK Position: Q3 2023 in Review

Marshall Wace sold out of HOOKIPA Pharma (HOOK) in Q3 2023, closing a stake of 2,427 shares — an estimated $21.4K sold.

Marshall Wace first reported a position in HOOK in Q2 2023 and held it in 1 quarter. The position peaked at $21.4K in Q2 2023. 44 funds tracked by Wall St. Rank hold HOOK as of Q3 2023.

Marshall Wace reported no remaining HOOKIPA Pharma position as of Q3 2023 after selling out during the quarter.
Marshall Wace sold 2,427 HOOKIPA Pharma shares in Q3 2023, an estimated $21.4K.
Marshall Wace first reported a position in HOOKIPA Pharma in Q2 2023 and held it in 1 quarter.
Marshall Wace's HOOKIPA Pharma position peaked at $21.4K in Q2 2023.
44 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2023.

Based on Marshall Wace's 13F filing for Q3 2023, filed 14 Nov 2023.